Study of cox-2 inhibitors could lead to new class of stroke drugs
A study, in mice, by investigators at the Stanford University School of Medicine points toward potential new therapies for stroke, the nation's third-leading cause of death and foremost single cause of severe neurological ...
Oct 3, 2011
0
0